ankario.com
About
Ankario is a cash-pay telehealth platform offering prescription weight-loss care (GLP-1 semaglutide and tirzepatide) and longevity programs (NAD+ and peptide-based protocols). Each patient completes an online health intake reviewed by an independent licensed provider; if treatment is appropriate, a prescription is issued and fulfilled by a licensed U.S. pharmacy partner and delivered to the door. Ankario does not accept insurance and states that submitting an intake does not guarantee a prescription.
Target Audience
Adults seeking prescription-based weight management or longevity and cellular energy support who prefer a fully online, cash-pay care experience without insurance, waiting rooms, or prior authorization, and who are willing to complete a telehealth clinical intake.
Selling Points
- Online-only care: intake, clinician review, prescription, and check-ins without a waiting room
- Cash-pay model with no insurance billing and no prior-authorization step
- Prescriptions reviewed by independent licensed providers, with transparent statements that a prescription is not guaranteed
- Fulfillment through licensed U.S. pharmacy partners, including 503A compounding pharmacies for longevity programs
- Structured four-step care journey with ongoing refills, dose adjustments, and scheduled check-ins
- Clear regulatory disclosures, including that compounded drugs are not FDA approved and HIPAA privacy practices
Main Products
- Semaglutide injections (GLP-1 weight loss program)
- Semaglutide tablets (GLP-1 weight loss program)
- Tirzepatide injection (GLP-1 weight loss program)
- Tirzepatide tablets (GLP-1 weight loss program)
- NAD+ nasal spray (longevity program)
- Peptide and longevity protocols prepared by 503A compounding pharmacies
Products
No products yet !